Highnoon Laboratories - HINOON
Rs 671.24
Change -12.76
On May 20
Trades end of day
| Last trade on | May 20, 2024 | Day's range | Rs 665.00 - 684.80 |
|---|---|---|---|
| Change | Rs -12.76 | 52 week range | Rs 322.10 - 725.00 |
| Open | Rs 684.00 | Volume | 4,702 |
| Close | Rs 671.24 | Previous Close | Rs 671.24 |
HINOON Trade Activity
| Period | High | Low | Volume |
|---|---|---|---|
| 1M | 711.87 | 531.63 | 1,501,920.00; Avg 75,096.00 |
| 3M | 711.87 | 500.07 | 2,082,435.00; Avg 35,904.00 |
| 6M | 711.87 | 450.33 | 4,057,335.00; Avg 33,531.00 |
| 1Y | 711.87 | 328.19 | 6,385,735.00; Avg 25,958.00 |
Latest Annual Financials
| Financial Year | 2022 | O/S Shares | 41.88m |
|---|---|---|---|
| Net Profit | Rs 2,417.17m | Market Cap | Rs 28,114.22m |
| EPS | 57.71 | P/E | 11.63 |
| Par | Rs 10.00 | Net Worth | Rs 2,409.93m |
| Dividend | Rs 2.00 | Dividend Yield | 0.00 |
| Right | 0.00 | Long Term Debt | 755.12 |
| Fixed Assets | 2,409.93m | Net Sales | 15,815.94m |
| Share High | 572.90 | Retained Earnings | 7,026.40m |
| Premium | Rs 0.00 | Bonus | 1.00% |
| Paid up Capital | 418.84m | Working Capital | 5,790.43m |
| Share Low | Rs 414.97 | Price at BOD Meeting | Rs 480.39 |
| Share Average | Rs 493.94 | Depreciation | 187.82m |
| Export Sales | 888.88m | Financial Expense | 54.40m |
The company is in the Pharmaceuticals sector.
Other Companies in This Sector
| Company | Current | Change | Date |
|---|---|---|---|
| Abbot Laboratories | Rs 666.00 | -1.62% | May 20, 2024 |
| AGP Limited | Rs 90.00 | -2.17% | May 20, 2024 |
| Citi Pharma Limited | Rs 31.00 | -3.13% | May 20, 2024 |
| Ferozsons Laboratories Limited | Rs 247.47 | -2.19% | May 20, 2024 |
| Glaxosmithkline | Rs 135.44 | -3.88% | May 20, 2024 |
| Glaxo Healthcare Pakistan | Rs 120.23 | -3.20% | Jan 30, 2023 |
| Haleon Pakistan Limited | Rs 260.00 | -2.62% | May 20, 2024 |
| Highnoon Laboratories | Rs 671.24 | -1.87% | May 20, 2024 |
| Hoechst Pakistan Limited | Rs 1,429.19 | -6.40% | May 20, 2024 |
| IBL Healthcare Limited | Rs 33.54 | -2.81% | May 20, 2024 |
| IBL Healthcare Limited (r) | Rs 0.00 | 0.00% | May 20, 2024 |
| Macter International Limited | Rs 89.85 | -0.04% | May 16, 2024 |
| Macter International Limited (r) | Rs 0.00 | 0.00% | May 20, 2024 |
| Otsuka Pakistan Limited | Rs 126.95 | -0.60% | May 20, 2024 |
| Sanofi-aventis Pharmaceutical Pakistan Limited | Rs 870.00 | 0.00% | Oct 27, 2023 |
Shareholding Pattern
| Year | Individual | Institutions | Investment Companies | Foreign Investors | Government | Shareholders | Other |
|---|---|---|---|---|---|---|---|
| 2022 | 63.38% | 2.02% | 1.92% | 14.10% | 1.09% | 3,519.00 | 4.74% |
| 2021 | 64.72% | 2.02% | 0.63% | 14.13% | 1.09% | 3,391.00 | 7.08% |
| 2020 | 65.06% | 2.05% | 0.00% | 1.85% | 0.00% | 3,408.00 | 17.73% |
| 2019 | 73.03% | 6.70% | 0.63% | 1.83% | 1.09% | 3,377.00 | 1.21% |
| 2018 | 74.27% | 4.41% | 0.00% | 1.73% | 1.09% | 3,408.00 | 0.11% |
| 2017 | 75.51% | 3.59% | 0.00% | 1.74% | 0.00% | 3,239.00 | 1.41% |
| 2016 | 79.83% | 3.63% | 0.00% | 1.77% | 0.37% | 3,102.00 | 0.91% |
| 2015 | 83.21% | 4.08% | 0.00% | 1.75% | 0.22% | 2,997.00 | 1.68% |
| 2014 | 79.27% | 5.18% | 5.16% | 10.39% | 0.00% | 3,278.00 | 0.00% |
| 2013 | 80.82% | 4.45% | 4.54% | 10.19% | 0.00% | 2,840.00 | 0.00% |
| 2012 | 79.16% | 6.02% | 12.98% | 1.84% | 0.00% | 2,956.00 | 0.00% |
| 2011 | 77.80% | 7.35% | 4.55% | 10.30% | 0.00% | 3,121.00 | 0.00% |
| 2010 | 77.40% | 7.79% | 4.52% | 10.29% | 0.00% | 3,223.00 | 0.00% |
| 2009 | 76.33% | 5.15% | 8.19% | 10.33% | 0.00% | 3,376.00 | 0.00% |
| 2008 | 74.58% | 5.15% | 18.78% | 1.49% | 0.00% | 3,375.00 | 0.00% |
| 2007 | 76.14% | 5.15% | 17.46% | 1.25% | 0.00% | 3,287.00 | 0.00% |
| 2006 | 79.70% | 5.15% | 13.82% | 1.33% | 0.00% | 3,146.00 | 0.00% |
| 2005 | 79.70% | 6.14% | 5.82% | 8.34% | 0.00% | 3,103.00 | 0.00% |
| 2004 | 78.42% | 7.47% | 12.78% | 1.33% | 0.00% | 3,005.00 | 0.00% |
| 2003 | 79.13% | 6.93% | 12.77% | 1.17% | 0.00% | 3,083.00 | 0.00% |
| 2002 | 88.72% | 6.43% | 4.85% | 0.00% | 0.00% | 2,989.00 | 0.00% |